Advertisement News Archives - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

News

October 22, 2019

Knight Therapeutics to acquire Latin American pharma firm Biotoscana

Knight Therapeutics plans to acquire Brazilian pharma company Biotoscana Investments (GBT) for a price of around BRL1.16bn ($281m), which includes the latter’s financial debt.

Knight Therapeutics to acquire Latin American pharma firm Biotoscana